Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTED for Mild Thyroid Eye Disease
NCT02393183Phase 3Withdrawn
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASTED in thyroid eye disease (TED), sponsored by Iran University of Medical Sciences. Planned start Jul 2019; status: withdrawn.
02
Drugs
ASTED
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT02393183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393183.